Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Public health economic evaluation of screening for APC resistance (Leiden mutation) in new oral contraceptive users].

Medizinische Klinik (Munich, Germany : 1983) - 15 May 1996

Szucs T, Osterkorn D, Schramm W

Abstract excerpt

BACKGROUND: Thromboembolic events in users of oral contraceptives rank among the most important complications with potential economic consequences. It is well known that a large part of thromboembolic complications correlates with hereditary thrombophilias. The relative high prevalence of the newly described resistance of activated protein C and an easy test for it rise up the question if general screening of new...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to APC gene
Share to Germany

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mass Screening

Share to Mutation

Share to Oligopeptides

Share to Protein C

Share to Risk Factors

Source

Identifiers

PMID: 8709911

Genes

APC

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Public health economic evaluation of screening for APC resistance (Leiden mutation) in new oral contraceptive users].PMID 8709911Read ↗

Economic evaluation of a novel genetic screening test for risk of venous thromboembolism compared with standard of care in women considering combined hormonal contraception in Switzerland.Semantic proximity Read ↗

[Significance of hereditary thrombophilia for risk of thrombosis with oral contraceptives].Semantic proximity Read ↗

Impact of oral contraceptive use on APC-resistance: a prospective, randomized clinical trial with three low-dose preparations.Semantic proximity Read ↗

Extended anticoagulation for prevention of recurrent venous thromboembolism in carriers of factor V Leiden--cost-effectiveness analysis.Semantic proximity Read ↗

Genetic screening for the predisposition to venous thromboembolism: a cost-utility analysis of clinical practice in the Italian health care system.Semantic proximity Read ↗

Screening for factor V Leiden mutation before prescribing combination oral contraceptives.Semantic proximity Read ↗

[Screening for factor V Leiden mutation in women using combined hormonal contraceptives or hormone replacement therapy].Semantic proximity Read ↗

[Increased prevalence of APC-resistance (factor V Leiden mutation) in patients with postthrombotic syndrome].Semantic proximity Read ↗

[Oral contraception increases the chance of venous thrombosis in factor V Leiden mutation].Semantic proximity Read ↗

New Oral Anticoagulants Versus Low Molecular Weight Heparins for the Treatment of Cancer-associated Thrombosis: a Cost-effectiveness AnalysisSemantic proximity Read ↗

Hormone replacement therapy and acquired resistance to activated protein C: results of a randomized, double-blind, placebo-controlled trial.Semantic proximity Read ↗

Screening with the activated protein C resistance assay yields significant savings in a patient population with low prevalence of factor V leiden.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.